VCCBH News


Pilot Grant Award Recipients 2021

October 1, 2021 by Office of the VCCBH

It is with great pleasure that we announce the recipients of our inaugural Vermont Center for Cardiovascular and Brain Health Pilot Grant Award, Drs Yangguang Ou and David Punihaole.

It is with great pleasure that we announce the recipients of our inaugural Vermont Center for Cardiovascular and Brain Health Pilot Grant Award, Drs Yangguang Ou and David Punihaole.

Drs Ou and Punihaole are newly appointed Assistant Professors in the Department of Chemistry and are Pipeline Investigators in our Center. Their work will focus on the use of novel chemical imaging and rapid electrochemical sensing techniques to assess the pathophysiology of variant amyloid-β fibrils involved in Alzheimer’s Disease and Cerebral Amyloid Angiopathy and is summarized below:

_______

Abnormal function of brain blood vessels and loss of function of brain cells contribute to cognitive decline in older people. These abnormalities are present in two related brain diseases, Alzheimer’s disease and cerebral amyloid angiopathy. In these disorders, fibrils made up of amyloid-b (Ab) peptides are deposited in the brain. These fibrils damage the cells and blood vessels in the brain.  They may cause these diseases and contribute to their severity. This research has two aims. We will develop bioanalytical methods to 1) monitor how Ab fibrils interact with cell membranes in brain tissue and brain blood vessels, and 2) measure molecules released from these interactions that contribute to cell death.  We will develop novel chemical imaging and rapid electrochemical sensing techniques to do this. We hope to understand the effects of Ab fibrils on the progression and outcome of Alzheimer’s disease and cerebral amyloid angiopathy. Our long-term goal is to better understand causes of Alzheimer’s disease and cerebral amyloid angiopathy.  We hope that this will guide the development of medications for prevention and treatment of these conditions.

This award, supported wholly by funds from UVM entities, provides $200,000 over 2 years to fund meritorious research from early career faculty. We are very grateful to Deans from the Colleges of Medicine, Nursing & Health Sciences, Arts & Sciences, Engineering & Mathematical Sciences, and the Graduate College, as well as the Cardiovascular Research Institute of Vermont, for their support of this program. In addition, we would like to acknowledge matching fund support from the Department of Chemistry.
_______

Please watch for our announcement for the next VCCBH Pilot Grant Award opportunity. We will announce this in December and will be accepting letters of intent until February 4, 2021. As for this year, we will be seeking applications from pairs of early career investigators, so now is the time to start thinking about your application.



Recent Stories and Publications Featuring VCCBH Members


Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 2, 2024

Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted August 21, 2024

Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5 at Magdalen College in Oxford, United Kingdom.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 31, 2024

A collaborative research team co-led by investigators David Jangraw, Ph.D., M.S., and Denise Peters, Ph.D., D.P.T., PT, has been awarded the 2024 Armin Grams Memorial Research Award by the Center on Aging. 

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 10, 2024

Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis Center.

Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases

Posted May 15, 2024

John Salogiannis, Ph.D., assistant professor of molecular physiology and biophysics, and members of his lab team—Allison (Morrissey) Langley, lab technician and Ph.D. candidate in cellular, molecular, and biomedical sciences; Sarah Abeling-Wang, lab research technician; and Erinn Wagner, UVM undergraduate biology major—have their first preprint*: “Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases.” The team’s research is supported by an NIH Maximizing Investigators’ Research Award (MIRA or R35) for early-stage investigators.

The University of Vermont Center on Aging Newsletter

Posted May 2024

Katharine Cheung, M.D., Ph.D., M.Sc., interim director of the UVM Center on Aging, associate director for research, and assistant professor of medicine, and her mentee, medical student Susanna Schuler ’26, presented their research findings at the American Academy of Hospice and Palliative Medicine State of the Science meeting on March 23 in Phoenix, Arizona.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted March 6, 2024

A study by a nationwide collaborative group, including Larner scientists Mary Cushman, M.D., M.Sc., University of Vermont Distinguished Professor and co-director of the Vermont Center for Cardiovascular and Brain Health, Russell Tracy, Ph.D., University of Vermont Distinguished Professor and director of UVM’s Laboratory for Clinical Biochemistry Research, Margaret Doyle Ph.D., associate professor of Pathology and Laboratory Medicine and co-director of the Laboratory of Clinical Biochemistry, and Rebekah Boyle, M.S., was recently published in Nature Communications.

 

UVM Scientist Wins Chan Zuckerberg Initiative Grant to Tackle Neurodegenerative Diseases

Larner Scientist Seeks to Advance Neurodegeneration Research

February 22, 2024

Larner College of Medicine scientist Osama Harraz, Ph.D., M.Sc., and his colleague from the University of Maryland (UMD), Thomas Longden, Ph.D., are recipients of a prestigious Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network (NCDN).